C. C. Sanders

1.0k total citations
29 papers, 810 citations indexed

About

C. C. Sanders is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, C. C. Sanders has authored 29 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Medicine, 13 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in C. C. Sanders's work include Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). C. C. Sanders is often cited by papers focused on Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). C. C. Sanders collaborates with scholars based in United States and Belgium. C. C. Sanders's co-authors include William E. Sanders, Patricia A. Bradford, C Watanakunakorn, Kenneth S. Thomson, Herman Goossens, P. Descheemaeker, Margareta Ieven, David L. Dworzack, Edward A. Horowitz and Anton F. Ehrhardt and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

C. C. Sanders

29 papers receiving 753 citations

Peers

C. C. Sanders

PHARM

EPIDE

Giovanni Bonfiglio Italy

Kathrine Dornbusch Sweden

C. Pichardo Spain

Wen-Hwei Chen Taiwan

María Isabel Morosini Spain

Zerrin Aktaş Türkiye

Maria M. Traczewski United States

Antonios Markogiannakis Greece

Soichiro Kimura Japan

Gianluigi Lombardi Italy

Giovanni Bonfiglio Italy

C. C. Sanders

433 ×0.9

252 ×0.8

PHARM

196 ×1.0

EPIDE

205 ×1.3

50 ×0.4

Citations per year, relative to C. C. Sanders C. C. Sanders (= 1×) peers Giovanni Bonfiglio

Countries citing papers authored by C. C. Sanders

Since Specialization

Citations

This map shows the geographic impact of C. C. Sanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. C. Sanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. C. Sanders more than expected).

Fields of papers citing papers by C. C. Sanders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. C. Sanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. C. Sanders. The network helps show where C. C. Sanders may publish in the future.

Co-authorship network of co-authors of C. C. Sanders

This figure shows the co-authorship network connecting the top 25 collaborators of C. C. Sanders. A scholar is included among the top collaborators of C. C. Sanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. C. Sanders. C. C. Sanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomson, Kenneth S., Stephen A. Chartrand, C. C. Sanders, & Stan L. Block. (1999). In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance. Journal of Antimicrobial Chemotherapy. 43(suppl_3). 15–19. 14 indexed citations

Ehrhardt, Anton F. & C. C. Sanders. (1997). Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli. Antimicrobial Agents and Chemotherapy. 41(11). 2570–2572. 2 indexed citations

Descheemaeker, P., et al.. (1997). Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. Journal of Clinical Microbiology. 35(9). 2191–2197. 107 indexed citations

Bradford, Patricia A. & C. C. Sanders. (1995). Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 39(2). 308–313. 19 indexed citations

Thomson, Kenneth S., C. C. Sanders, & Herman Chmel. (1993). Imipenem resistance inEnterobacter. European Journal of Clinical Microbiology & Infectious Diseases. 12(8). 610–613. 9 indexed citations

Bradford, Patricia A. & C. C. Sanders. (1993). Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam. Antimicrobial Agents and Chemotherapy. 37(2). 251–259. 11 indexed citations

Sanders, C. C.. (1992). Review of Preclinical Studies with Ofloxacin. Clinical Infectious Diseases. 14(2). 526–538. 18 indexed citations

Bradford, Patricia A. & C. C. Sanders. (1992). Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam. Antimicrobial Agents and Chemotherapy. 36(2). 394–400. 21 indexed citations

Vermoesen, Annick, Joeri Vercammen, C. C. Sanders, D. Courtheyn, & H.F. De Brabander. (1991). Comparison of two mass-selective detectors with special reference to the analysis of residues of anabolics. Journal of Chromatography B Biomedical Sciences and Applications. 564(2). 384–391. 7 indexed citations

10.

Sanders, C. C.. (1989). beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance. Antimicrobial Agents and Chemotherapy. 33(8). 1313–1317. 22 indexed citations

11.

Sanders, C. C.. (1988). Ciprofloxacin: In Vitro Activity, Mechanism of Action, and Resistance. Clinical Infectious Diseases. 10(3). 516–527. 91 indexed citations

12.

Sanders, William E. & C. C. Sanders. (1988). Inducible -Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins. Clinical Infectious Diseases. 10(4). 830–838. 151 indexed citations

13.

Dworzack, David L., et al.. (1988). Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrobial Agents and Chemotherapy. 32(11). 1740–1741. 30 indexed citations

14.

Dworzack, David L., et al.. (1987). Efficacy of Ciprofloxacin in the Treatment of Nasopharyngeal Carriers of Neisseria meningitidis. The Journal of Infectious Diseases. 156(1). 211–213. 23 indexed citations

15.

Sanders, C. C. & C Watanakunakorn. (1986). Emergence of Resistance to -Lactams, Aminoglycosides, and Quinolones During Combination Therapy for Infection Due to Serratia marcescens. The Journal of Infectious Diseases. 153(3). 617–619. 54 indexed citations

16.

Dworzack, David L., et al.. (1984). Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrobial Agents and Chemotherapy. 25(4). 494–496. 2 indexed citations

17.

Sanders, C. C. & William E. Sanders. (1982). Sch 29482: Comparative activity against Enterobacteriaceae multiply-resistant to -lactam antibiotics and mycobacteria. Journal of Antimicrobial Chemotherapy. 9(suppl C). 59–69. 11 indexed citations

18.

Sanders, C. C. & William E. Sanders. (1982). Enocin: An Antibiotic Produced by Streptococcus salivarius That May Contribute to Protection Against Infections Due to Group A Streptococci. The Journal of Infectious Diseases. 146(5). 683–690. 40 indexed citations

19.

Sanders, William E. & C. C. Sanders. (1980). Sisomicin: A Review of Eight Years' Experience. Clinical Infectious Diseases. 2(2). 182–195. 5 indexed citations

20.

Sanders, C. C. & William E. Sanders. (1976). Sisomicin: A composite of comparative in vitro studies spanning six years. Infection. 4(S4). S317–S323. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact